디지털 외과 기술 시장 : 세계 및 지역별 분석 - 기술, 제품, 국가별 분석과 예측(2023-2033년)

The Global Digital Surgery Technologies Market Expected to Reach $12,997.3 Million by 2033

Introduction to Digital Surgery Technologies Market

The global digital surgery technologies market is projected to reach $12,997.3 million by 2033 from $783.2 million in 2023, growing at a CAGR of 32.43% during the forecast period 2023-2033. The key factors driving the growth of the global digital surgery technologies market include the increasing interest of technologists and start-ups in surgery-related innovation, improved precision offered by digital surgery techniques, and promising post-operative rehabilitation through pre-surgical planning.

Market Introduction

The global digital surgery technologies market consists of products such as surgical navigation and advanced visualization, surgical simulation systems, surgical planning, and surgical data science, as well as technology that includes augmented reality and virtual reality, AI algorithms, mixed reality, and other technologies.

Impact Analysis:

The digital surgery technologies market has made an impact in the following ways:

Integration of Augmented Reality (AR) and Virtual Reality (VR) in Surgical Procedures: The integration of AR and VR in surgical procedures has the potential to enhance patient safety, improve surgical outcomes, and advance the field of medicine through innovation and education. However, challenges such as technological limitations, regulatory issues, and the need for further validation through clinical studies must be addressed to fully realize the benefits of these technologies in clinical practice.

Increasing Investment and Funding for Digital Surgery Technologies: Digital surgery technologies, owing to their transformative potential to enhance precision, optimize workflows, and improve patient outcomes, are rapidly changing the landscape of healthcare. However, unlocking their full potential would require a significant influx of investment and funding. Investing in digital surgery technologies is not just about financial gains; it's an investment in the future of healthcare. By creating a supportive environment for innovation and attracting substantial funding, companies are unlocking the potential of these technologies to transform surgery, improve lives, and pave the way for a healthier future.

Market Segmentation:

Segmentation 1: by Technology

• Augmented Reality and Virtual Reality
• AI Algorithms
• Mixed Reality
• Other Technologies

Augmented Reality and Virtual Reality Segment to Continue Dominating the Digital Surgery Technologies Market (by Technology)

Augmented Reality and Virtual Reality: Augmented reality and virtual reality are playing a revolutionary role in digital surgery technology, impacting various stages of the surgical process and offering numerous benefits. Here's a breakdown of their key applications.

Augmented Reality (AR):

Enhanced Visualization: Surgeons can overlay real-time data such as vital signs, anatomical structures, and surgical instructions onto the patient's body through AR glasses or displays. This improves spatial awareness and decision-making during the surgery.

Intraoperative Guidance: AR can guide surgeons during minimally invasive procedures by highlighting critical structures and pathways in the surgical field, thereby minimizing tissue damage and improving accuracy.

Virtual Reality (VR):

Pre-Operative Planning and Rehearsal: Surgeons can create virtual models of the patient's anatomy and practice the planned surgery in VR, allowing for meticulous planning and risk mitigation before entering the operating room.

Patient Education and Informed Consent: VR can be used to educate patients about their upcoming surgery, allowing them to visualize the procedure and make informed decisions about their care.

AI Algorithms: AI algorithms are playing a transformative role in digital surgery technology, impacting various stages of the surgical process and offering numerous benefits. Here's a breakdown of their key applications.

• Pre-Operative Planning and Risk Assessment
• Intra-Operative Guidance and Assistance
• Post-Operative Care and Analysis

Mixed Reality: Mixed reality (MR) seamlessly blends elements of both augmented reality (AR) and virtual reality (VR) to create an interactive environment where real and virtual objects coexist and interact in real-time. This emerging technology is expected to play a significant role in the future of digital surgery, offering even greater possibilities than what AR and VR can achieve individually.

Other Technologies: Additional technologies include sensor technology embedded into surgical data science products, such as the Clotild connected guidewire by Sensome. Additionally, the Intra-Operative Positioning System (IOPS) by Centerline Biomedical utilizes GPS technology for endovascular procedures. IOPS serves as a surgical navigation technology, facilitating precise surgical maneuvers and simplifying complex procedures, and other technologies

Based on application, the digital surgery technologies market has been led by augmented reality and virtual reality, which held a 48.40% share in 2022.

Segmentation 2: by Product

• Surgical Navigation and Advanced Visualization
• Surgical Simulation Systems
• Surgical Planning
• Surgical Data Science

Surgical Navigation and Advanced Visualization Segment to Continue Dominating the Digital Surgery Technologies Market (by Product)

Based on product, the digital surgery technologies market has been led by surgical navigation and advanced visualization, which held a 48.08% share in 2022.

Segmentation 3: by Region

• North America - U.S., Canada
• Europe - U.K., Germany, France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific - China, Japan, India, South Korea, Australia, and Rest-of-Asia-Pacific
• Rest-of-the-World

Japan dominated the Asia-Pacific digital surgery technologies market in 2022. The increasing business expansion by the players in the market is one of the growing factors in this region. For instance, in December 2023, Miyazaki University in Japan utilized EchoPixel's technology.

The Japanese government recognizes the potential of digital surgery technologies and is actively promoting their development and manufacturing.

Recent Developments in the Digital Surgery Technologies Market

• In July 2023, Activ Surgical secured $15 million in funding led by ARTIS Ventures to further the advancement of autonomous and collaborative surgery.
• In July 2023, Augmedics fortified its AR/AI portfolio through the planned acquisition of Surgalign Digital Health assets.
• In June 2023, Augmedics secured $82.5 million to expedite the adoption of augmented reality in spine surgery.
• In January 2024, Rescale and Caresyntax expanded their collaboration to provide a scalable platform for AI-powered simulation and intelligence in surgery. The collaboration with the World Economic Forum enhanced access to surgical care and contributed to health equity.
• In December 2023, Caresyntax announced a strategic collaboration with AAICO aimed at expanding AI-based solutions in healthcare.
• In December 2023, Miyazaki University in Japan utilized EchoPixel's technology.
• In February 2023, EchoPixel's True3D received medical device registration in Japan.
• In June 2023, Osso VR announced the launch of Osso Academy, a comprehensive virtual reality (VR) training program specifically designed for academic medical centers and residency programs.

Demand - Drivers and Limitations

Market Demand Drivers:

Increasing Interest of Technologists and Start-Ups: Recent advancements in technology, encompassing both software and hardware, have prompted active involvement from companies, investors, surgeons, and healthcare systems to expedite the digitization of surgical procedures. The goal is to enhance surgery outcomes across a spectrum of complexities and deliver personalized surgical care. As value-based care models gain traction in global health systems, both public and private entities have captured stakeholders' interest through heightened investment in digital surgery.

This increased funding is laying the groundwork for revolutionizing surgical practices, promising heightened efficiency and precision in the execution of procedures. For instance, in January 2022, Johnson & Johnson partnered with Microsoft to advance digital surgery solutions. Similarly, in January 2024, Caresyntax announced the launch of a novel Real-World Evidence (RWE) program and software portfolio of digital catalysts aimed at facilitating the commercial acceleration of its medtech partners.

Increased Adoption of AR/VR Surgical Simulators: The augmented adoption of virtual reality and augmented reality surgical simulation represents a transformative shift in surgical education and training, offering numerous benefits such as enhanced immersion, precise skill development, safe learning environments, personalized training, collaborative learning experiences, continuous education and assessment, and opportunities for research and innovation. As these technologies continue to evolve, they are poised to play an increasingly integral role in shaping the future of surgical practice and education.

Improved Precision and Promising Post-Operative Rehabilitation through Pre-Surgical Planning: Personalized pre-surgical planning using 3D-printed patient models and AI simulations enables surgeons to perform highly precise procedures, leading to faster healing, reduced complications, and a more effective post-operative rehabilitation experience for patients.

By investing in thorough pre-surgical planning, surgeons can achieve pinpoint accuracy during surgery, resulting in shorter hospital stays, less pain for patients, and a smoother path to recovery through targeted rehabilitation programs.

Market Challenges:

Substantial Expenses Associated with Installation and Maintenance: The substantial expenses associated with the installation and maintenance of digital surgery technology products underscore the importance of careful financial planning and resource allocation by healthcare organizations. Despite the initial investment and ongoing costs, the benefits of digital surgery technology in terms of improved patient outcomes, enhanced surgical precision, and operational efficiency justify the expenditure for many healthcare providers.

Requirement of Additional Surgical Training for the Use of Digital Surgery Products: The requirement for additional surgical training for the use of digital surgery products presents challenges related to the complexity of new technology, the steep learning curve, limited training resources, integration into surgical workflow, costs of training and implementation, patient safety considerations, and credentialing requirements. Overcoming these challenges requires a coordinated effort from healthcare institutions, manufacturers, professional organizations, and individual surgeons to ensure that adequate training and support are provided to facilitate the safe and effective use of digital surgery products in clinical practice.

Market Opportunities:

Ensuring Data Security and Privacy in Digital Surgery: Healthcare organizations can ensure data security and privacy in digital surgery, thereby safeguarding patient information and maintaining trust in healthcare systems. The revolution in digital surgery brings immense benefits, but with it comes a critical responsibility, i.e., safeguarding patient data security and privacy. As sensitive information flows through complex systems, robust measures are essential to build trust and ensure ethical implementation.

Growing Use of Digital Surgery Technologies Potentially Offsetting the Initial Investment over Time in Hospitals: The growing use of digital surgery technologies in hospitals has the potential to offset the initial investment over time by reducing operating costs, minimizing complications and revisions, enhancing patient outcomes, optimizing resource utilization, providing a competitive advantage, and delivering long-term ROI. As these technologies continue to evolve and become more widespread, their value proposition for hospitals in terms of cost savings and operational efficiencies is expected to further increase.

How can this report add value to an organization?

Product/Innovation Strategy: The global digital surgery technologies market has been extensively segmented based on various categories, such as technology, products, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments, i.e., nearly 33.82% of the total developments in the global digital surgery technologies market were between January 2020 and January 2024.

Competitive Strategy: The global digital surgery technologies market has numerous established players with product portfolios. Key players in the global digital surgery technologies market analyzed and profiled in the study involve established players offering products for digital surgery.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
• Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the technology, product, and region were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of digital surgery technologies.
• The market contribution of the digital surgery technologies anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
• The scope of availability of digital surgery technologies in a particular region has been assessed based on a comprehensive analysis of companies' prospects, regional end-user perception, and other factors impacting the launch of digital surgery technologies in that region.
• The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2020-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2033.
• Revenues of the companies have been referenced from their annual reports for FY2020-FY2022. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
• Regional distribution of the market revenue has been estimated based on the companies in each region and the adoption rate of digital surgery technologies. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2023-2033.
• The market has been mapped based on the available digital surgery technologies. All the key companies with significant offerings in this field have been considered and profiled in this report.
• Market strategies and developments of key players have been considered for the calculation of the potential of the market in the forecast period.

Primary Research:

The primary sources involve industry experts in the digital surgery technologies market, including the market players offering digital surgery technologies solutions. Resources such as CXOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report's segmentation and key qualitative findings for digital surgery technologies
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Validation of the numbers of the different segments of the market in focus
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• European Medicines Agency (EMA), Food and Drug Administration (FDA), Frontiers, World Health Organization (WHO), American College of Surgeons (ACS), and National Center for Biotechnology Information (NCBI), among others
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their portfolios
• Gold standard magazines, journals, whitepapers, press releases, and news articles
• Databases

The key data points taken from the secondary sources include:

• Segmentation and percentage share estimates
• Companies' and countries' understanding and data for market value estimation
• Key industry/market trends
• Developments among top players
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global digital surgery technologies market include:

• Activ Surgical
• Augmedics Ltd.
• Brainlab AG
• Caresyntax
• Centerline Biomedical
• EchoPixel, Inc.
• FundamentalVR
• Medical Realities Ltd.
• Medtronic plc
• Osso VR Inc.
• PrecisionOS
• Stryker Corporation
• Surgical Science Sweden AB
• VirtaMed AG

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Integration of Augmented Reality (AR) and Virtual Reality (VR) in Surgical Procedures
  • 1.1.2 Increasing Investment and Funding for Digital Surgery Technologies
  • 1.1.3 Increasing Partnerships among Players
• 1.2 R&D Review
  • 1.2.1 Patent Filing Trend (by Year, Country)
• 1.3 Database of the FDA-Approved AI/ML-Based Medical Devices and Algorithms, 2023
• 1.4 Regulatory Landscape
  • 1.4.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
    • 1.4.1.1 Restraints in the Current Regulatory Process for AI/ML-Based Medical Device/Algorithm
  • 1.4.2 Regulatory Framework in the U.S.
  • 1.4.3 Regulatory Framework in Europe
    • 1.4.3.1 Changes in Rule
    • 1.4.3.2 New Rules in the Annexure VIII
    • 1.4.3.3 Major Changes in the EU due to the Implementation of MDR
      • 1.4.3.3.1 Expanded Device Definitions Requiring Re-Examination of the Current Classification of All Devices
      • 1.4.3.3.2 Quality Management System
      • 1.4.3.3.3 Technical File
      • 1.4.3.3.4 Need to Comply with New Identification and Traceability (UDI) Requirements
      • 1.4.3.3.5 More Emphasis on Post-Market Surveillance
      • 1.4.3.3.6 Role of Internal Audits and Requirement of Audits to be Strengthened
      • 1.4.3.3.7 Dedicated Personnel for MDR Compliance
  • 1.4.4 Regulatory Framework in Japan
  • 1.4.5 Regulatory Framework in China
  • 1.4.6 Regulatory Framework in Other Countries
    • 1.4.6.1 Regulatory Framework in India
    • 1.4.6.2 Regulatory Framework in Latin America
    • 1.4.6.3 Regulatory Framework in the Middle East and Africa
  • 1.4.7 Consortiums, Associations, and Regulatory Bodies
  • 1.4.8 Restraints in the Current Regulatory Process for AI/ML-Based Medical Devices/Algorithms
• 1.5 Consumer Analysis
  • 1.5.1 End-Result Analysis
• 1.6 Case Studies
  • 1.6.1 Case Study: Training for Orthopedic Surgery
  • 1.6.2 Case Study: Enhancing Surgical Performance and Teamwork through Video-Based Analytics
  • 1.6.3 Case Study: Surgical Navigation, and Advanced Visualization Systems, Augmented Reality (AR)
  • 1.6.4 Case Study: Enhancing Surgical Skill
• 1.7 Impact Analysis for Key Global Events - COVID-19
• 1.8 Market Dynamics: Overview
  • 1.8.1 Market Drivers
    • 1.8.1.1 Increasing Interest of Technologists and Start-Ups
    • 1.8.1.2 Increased Adoption of AR/VR Surgical Simulators
    • 1.8.1.3 Improved Precision and Promising Post-Operative Rehabilitation through Pre-Surgical Planning
  • 1.8.2 Market Opportunities
    • 1.8.2.1 Ensuring Data Security and Privacy in Digital Surgery
    • 1.8.2.2 Growing Use of Digital Surgery Technologies Potentially Offsetting the Initial Investment over Time in Hospitals
  • 1.8.3 Market Challenges
    • 1.8.3.1 Substantial Expenses Associated with Installation and Maintenance
    • 1.8.3.2 Requirement of Additional Surgical Training for Use of Digital Surgery Products

2 Global Digital Surgery Technologies Market (by Application)

• 2.1 Application Segmentation
• 2.2 Application Summary
• 2.3 Global Digital Surgery Technologies Market (by Technology)
  • 2.3.1 AI Algorithms
  • 2.3.2 Augmented Reality and Virtual Reality
  • 2.3.3 Mixed Reality
  • 2.3.4 Other Technologies

3 Global Digital Surgery Technologies Market (by Product)

• 3.1 Product Segmentation
• 3.2 Product Summary
  • 3.2.1 Surgical Simulation Systems
  • 3.2.2 Surgical Data Science
  • 3.2.3 Surgical Navigation and Advanced Visualization
  • 3.2.4 Surgical Planning

4 Regions

• 4.1 Regional Summary
• 4.2 North America
  • 4.2.1 Regional Overview
  • 4.2.2 Key Market Participants in North America
  • 4.2.3 Driving Factors for Market Growth
  • 4.2.4 Factors Challenging the Market
  • 4.2.5 Application
  • 4.2.6 Product
  • 4.2.7 U.S.
  • 4.2.8 Canada
• 4.3 Europe
  • 4.3.1 Regional Overview
  • 4.3.2 Key Market Participants in Europe
  • 4.3.3 Driving Factors for Market Growth
  • 4.3.4 Factors Challenging the Market
  • 4.3.5 Application
  • 4.3.6 Product
  • 4.3.7 France
  • 4.3.8 Germany
  • 4.3.9 U.K.
  • 4.3.10 Spain
  • 4.3.11 Italy
  • 4.3.12 Rest-of-Europe
• 4.4 Asia-Pacific
  • 4.4.1 Regional Overview
  • 4.4.2 Key Market Participants in Asia-Pacific
  • 4.4.3 Driving Factors for Market Growth
  • 4.4.4 Factors Challenging the Market
  • 4.4.5 Application
  • 4.4.6 Product
  • 4.4.7 China
  • 4.4.8 India
  • 4.4.9 Japan
  • 4.4.10 Australia
  • 4.4.11 South Korea
  • 4.4.12 Rest-of-Asia-Pacific
• 4.5 Rest-of-the-World
  • 4.5.1 Regional Overview
  • 4.5.2 Key Market Participants in Rest-of-the-World
  • 4.5.3 Driving Factors for Market Growth
  • 4.5.4 Factors Challenging the Market
  • 4.5.5 Application
  • 4.5.6 Product

5 Markets -Competitive Benchmarking & Company Profiles

• 5.1 Next Frontiers
• 5.2 Geographic Assessment
• 5.3 Market Share Analysis
• 5.4 Product Benchmarking
• 5.5 Company Profile
  • 5.5.1 Activ Surgical
    • 5.5.1.1 Overview
    • 5.5.1.2 Top Products
    • 5.5.1.3 Target Customers/End Users
    • 5.5.1.4 Key Developments
    • 5.5.1.5 Top Competitors
    • 5.5.1.6 Key Personnel
    • 5.5.1.7 Analyst View
  • 5.5.2 Augmedics Ltd.
    • 5.5.2.1 Overview
    • 5.5.2.2 Key Developments
    • 5.5.2.3 Top Products
    • 5.5.2.4 Target Customers/End Users
    • 5.5.2.5 Top Competitors
    • 5.5.2.6 Key Personnel
    • 5.5.2.7 Analyst View
  • 5.5.3 Brainlab AG
    • 5.5.3.1 Overview
    • 5.5.3.2 Key Developments
    • 5.5.3.3 Top Products
    • 5.5.3.4 Target Customers/End Users
    • 5.5.3.5 Top Competitors
    • 5.5.3.6 Key Personnel
    • 5.5.3.7 Analyst View
  • 5.5.4 Caresyntax
    • 5.5.4.1 Overview
    • 5.5.4.2 Key Developments
    • 5.5.4.3 Top Products
    • 5.5.4.4 Target Customers/End Users
    • 5.5.4.5 Top Competitors
    • 5.5.4.6 Key Personnel
    • 5.5.4.7 Analyst View
  • 5.5.5 Centerline Biomedical
    • 5.5.5.1 Overview
    • 5.5.5.2 Top Products
    • 5.5.5.3 Target Customers/End Users
    • 5.5.5.4 Key Developments
    • 5.5.5.5 Top Competitors
    • 5.5.5.6 Key Personnel
    • 5.5.5.7 Analyst View
  • 5.5.6 EchoPixel, Inc.
    • 5.5.6.1 Overview
    • 5.5.6.2 Top Products
    • 5.5.6.3 Target Customers/End Users
    • 5.5.6.4 Key Developments
    • 5.5.6.5 Top Competitors
    • 5.5.6.6 Key Personnel
    • 5.5.6.7 Analyst View
  • 5.5.7 FundamentalVR
    • 5.5.7.1 Overview
    • 5.5.7.2 Top Products
    • 5.5.7.3 Target Customers/End Users
    • 5.5.7.4 Key Developments
    • 5.5.7.5 Top Competitors
    • 5.5.7.6 Key Personnel
    • 5.5.7.7 Analyst View
  • 5.5.8 Medical Realities Ltd.
    • 5.5.8.1 Overview
    • 5.5.8.2 Top Products
    • 5.5.8.3 Target Customers/End Users
    • 5.5.8.4 Top Competitors
    • 5.5.8.5 Key Personnel
    • 5.5.8.6 Analyst View
  • 5.5.9 Medtronic plc
    • 5.5.9.1 Overview
    • 5.5.9.2 Top Products
    • 5.5.9.3 Target Customers/End Users
    • 5.5.9.4 Key Developments
    • 5.5.9.5 Top Competitors
    • 5.5.9.6 Key Personnel
    • 5.5.9.7 Analyst View
  • 5.5.10 Osso VR Inc.
    • 5.5.10.1 Overview
    • 5.5.10.2 Top Products
    • 5.5.10.3 Target Customers/End Users
    • 5.5.10.4 Key Developments
    • 5.5.10.5 Top Competitors
    • 5.5.10.6 Key Personnel
    • 5.5.10.7 Analyst View
  • 5.5.11 PrecisionOS
    • 5.5.11.1 Overview
    • 5.5.11.2 Top Products
    • 5.5.11.3 Target Customers/End Users
    • 5.5.11.4 Top Competitors
    • 5.5.11.5 Key Developments
    • 5.5.11.6 Key Personnel
    • 5.5.11.7 Analyst View
  • 5.5.12 Stryker Corporation
    • 5.5.12.1 Overview
    • 5.5.12.2 Top Products
    • 5.5.12.3 Target Customers/End Users
    • 5.5.12.4 Key Developments
    • 5.5.12.5 Top Competitors
    • 5.5.12.6 Key Personnel
    • 5.5.12.7 Analyst View
  • 5.5.13 Surgical Science Sweden AB
    • 5.5.13.1 Overview
    • 5.5.13.2 Top Products
    • 5.5.13.3 Target Customers/End Users
    • 5.5.13.4 Key Developments
    • 5.5.13.5 Top Competitors
    • 5.5.13.6 Key Personnel
    • 5.5.13.7 Analyst View
  • 5.5.14 VirtaMed AG
    • 5.5.14.1 Overview
    • 5.5.14.2 Top Products
    • 5.5.14.3 Target Customers/End Users
    • 5.5.14.4 Key Developments
    • 5.5.14.5 Top Competitors
    • 5.5.14.6 Key Personnel
    • 5.5.14.7 Analyst View

6 Research Methodology

• 6.1 Data Sources
  • 6.1.1 Primary Data Sources
  • 6.1.2 Secondary Data Sources
  • 6.1.3 Data Triangulation
• 6.2 Market Estimation and Forecast